MAP2K7 and melanoma: Thus far, the miR-204, miR-211, as well as miR-410-3p, were shown to be induced by BRAF or MEK inhibitor and to contribute to resistance to BRAF inhibitor in melanoma by enhancing the activity of downstream pathways, such as MEK or ERK [39,40,50].